Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
- بيانات النشر:
Original Publication: [Malden, MA] : John Wiley & Sons Ltd., c2012-
- الموضوع:
- نبذة مختصرة :
Purpose: To examine the benefit of telehealth over current delivery options in oncology practices without genetic counselors.
Methods: Participants meeting cancer genetic testing guidelines were recruited to this multi-center, randomized trial comparing uptake of genetic services with remote services (telephone or videoconference) to usual care in six predominantly community practices without genetic counselors. The primary outcome was the composite uptake of genetic counseling or testing. Secondary outcomes compare telephone versus videoconference services.
Results: 147 participants enrolled and 119 were randomized. Eighty percent of participants in the telehealth arm had genetic services as compared to 16% in the usual care arm (OR 30.52, p < 0.001). Five genetic mutation carriers (6.7%) were identified in the telehealth arm, compared to none in the usual care arm. In secondary analyses, factors associated with uptake were lower anxiety (6.77 vs. 8.07, p = 0.04) and lower depression (3.38 vs. 5.06, p = 0.04) among those who had genetic services. There were no significant differences in change in cognitive or affective outcomes immediately post-counseling and at 6 and 12 months between telephone and videoconference arms.
Conclusion: Telehealth increases uptake of genetic counseling and testing at oncology practices without genetic counselors and could significantly improve identification of genetic carriers and cancer prevention outcomes.
(© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
- References:
Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1772-1780. (PMID: 28971986)
Cancer Control. 2004 Jul-Aug;11(4):236-44. (PMID: 15284715)
J Genet Couns. 2015 Dec;24(6):961-70. (PMID: 25833335)
Telemed J E Health. 2016 Feb;22(2):87-113. (PMID: 26624248)
J Pediatr Surg. 1999 Jan;34(1):137-41; discussion 141-2. (PMID: 10022159)
Psychosom Med. 1979 May;41(3):209-18. (PMID: 472086)
Genet Med. 2012 Jul;14(7):681-7. (PMID: 22481132)
J Med Internet Res. 2016 Feb 01;18(2):e23. (PMID: 26831751)
J Natl Cancer Inst. 2014 Nov 05;106(12):. (PMID: 25376862)
Telemed J E Health. 2018 Feb;24(2):130-138. (PMID: 28737998)
JCO Precis Oncol. 2018;2:. (PMID: 31819920)
Clin Genet. 2020 Apr;97(4):601-609. (PMID: 32022897)
Genet Med. 2015 Jun;17(6):467-75. (PMID: 25232856)
Genet Test. 2004 Spring;8(1):23-9. (PMID: 15140371)
Genet Test Mol Biomarkers. 2019 Feb;23(2):75-83. (PMID: 30676117)
Health Psychol. 2002 Nov;21(6):564-72. (PMID: 12433008)
J Gen Intern Med. 2008 May;23(5):561-6. (PMID: 18335281)
JAMA Oncol. 2018 Aug 1;4(8):1066-1072. (PMID: 29801090)
J Genet Couns. 2021 Apr;30(2):563-573. (PMID: 33131182)
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. (PMID: 6880820)
Genet Med. 2020 Aug;22(8):1401-1406. (PMID: 32376981)
Genet Med. 2011 Mar;13(3):197-200. (PMID: 21283011)
Telemed J E Health. 2021 Jan;27(1):68-73. (PMID: 32294027)
J Genet Couns. 2018 Apr;27(2):339-348. (PMID: 29243007)
Genet Med. 2015 Jun;17(6):485-92. (PMID: 25297947)
JCO Precis Oncol. 2018;2:. (PMID: 32095738)
Psychooncology. 2005 Dec;14(12):1060-74. (PMID: 15937976)
J Natl Cancer Inst. 2018 Sep 1;110(9):985-993. (PMID: 29490071)
J Clin Oncol. 2014 Mar 1;32(7):618-26. (PMID: 24449235)
Genet Med. 2014 Oct;16(10):795. (PMID: 25290261)
Ann Intern Med. 2005 Sep 6;143(5):355-61. (PMID: 16144894)
Genet Med. 2012 Sep;14(9):765-76. (PMID: 22498847)
J Genet Couns. 2019 Jun;28(3):673-691. (PMID: 30825358)
Eur J Hum Genet. 2016 Aug;24(9):1255-61. (PMID: 26785833)
J Genet Couns. 2017 Aug;26(4):697-715. (PMID: 27826805)
J Clin Oncol. 2016 Aug 20;34(24):2914-24. (PMID: 27325848)
- Grant Information:
Basser Center
- Contributed Indexing:
Keywords: alternative service delivery; cancer genetics; cancer predisposition syndromes; genetic counseling; genetic testing; genetics; telegenetics; telehealth; telemedicine
- الموضوع:
Date Created: 20210608 Date Completed: 20211231 Latest Revision: 20211231
- الموضوع:
20250114
- الرقم المعرف:
PMC8267134
- الرقم المعرف:
10.1002/cam4.3968
- الرقم المعرف:
34102012
No Comments.